Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis

Cytotherapy

Volumn 13, Issue 9, 2011, Pages 1036-1046

  Forostyak, Serhiy ^a,b   Jendelova, Pavla ^a,b   Kapcalova, Miroslava ^a,b   Arboleda, David ^a,b   Sykova, Eva ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

amyotrophic lateral sclerosis; human superoxide dismutase 1; mesenchymal stromal cells; motor neurons; neurodegenerative diseases; stem cells

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOSPORIN A; GREEN FLUORESCENT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL COUNT; CELL CULTURE; CELL ISOLATION; CELL SIZE; DISEASE COURSE; GENE OVEREXPRESSION; GRIP STRENGTH; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTRASPINAL DRUG ADMINISTRATION; INTRAVENOUS ADMINISTRATION; LIFE EXTENSION; LIFE SUSTAINING TREATMENT; LUMBAR SPINE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTONEURON; MOTOR ACTIVITY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RAT; SPINAL CORD MOTONEURON; THORACIC SPINE; TRANSGENIC RAT;

EID: 80052882553     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.592521     Document Type: Article

References (42)

1. Rowland LP. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1998;160(Suppl 1):S6-24. (Pubitemid 28522512)
2. Bento-Abreu A, Van Damme P, Van Den Bosch L, Robberecht W. The neurobiology of amyotrophic lateral sclerosis. Eur J Neurosci . 2010;31:2247-65.
3. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62. (Pubitemid 23087289)
4. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772-5. (Pubitemid 24227760)
5. Nagano I, Ilieva H, Shiote M, Murakami T, Yokoyama M, Shoji M, et al. Therapeutic benefi t of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis. J Neurol Sci. 2005;235:61-8. (Pubitemid 41039094)
6. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413-7. (Pubitemid 38715132)
7. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci. 2005;8: 85-92. (Pubitemid 41236736)
8. Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, et al. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci. 2007;27:304-7. (Pubitemid 46106003)
9. Mazzini L, Fagioli F, Boccaletti R. Stem-cell therapy in amyotrophic lateral sclerosis. Lancet. 2004;364:1936-7. (Pubitemid 39574591)
10. Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:158-61. (Pubitemid 37184884)
11. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R, et al. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res. 2006;28:523-6. (Pubitemid 44141321)
12. Silani V, Cova L, Corbo M, Ciammola A, Polli E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet. 2004; 364:200-2. (Pubitemid 38891692)
13. Staats KA, Van Den Bosch L. Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival. J Biol Phys. 2009;35:337-46.
14. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105:1815-22. (Pubitemid 40223708)
15. L e Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy. 2003;5:485-9. (Pubitemid 38028708)
16. Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, Sykova E. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma. 2006;23:1379-91. (Pubitemid 46489623)
17. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002;59:514-23. (Pubitemid 34919983)
18. Z hang J, Li Y, Chen J, Yang M, Katakowski M, Lu M, et al. Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res. 2004;1030:19-27. (Pubitemid 39563824)
19. Basso DM, Beattie MS, Bresnaham JC. A sensitive and reliable locomotor rating scale for open fi eld testing in rats. J Neurotrauma. 1995;12:1-12.
20. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. Green miceas a source of ubiquitous green cells. FASEB Lett. 1997;407:313-9. (Pubitemid 27199450)
21. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defi ning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-17. (Pubitemid 44269669)
22. Mouton PR. Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists. The Johns Hopkins University Press, Baltimore, MD, USA; 2002.
23. Bjugn R, Gundersen HJ. Estimate of the total number of neurons and glial and endothelial cells in the rat spinal cord by means of the optical dissector. J Comp Neurol. 1993 15;328: 406-14. (Pubitemid 23040109)
24. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 1997;277:559-62. (Pubitemid 27369003)
25. Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ, et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 2000;288:335-9. (Pubitemid 30226195)
26. Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinfl ammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008;31:395-405.
27. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57:874-82. (Pubitemid 40798626)
28. Lescaudron L, Unni D, Dunbar GL. Autologous adult bone marrow stem cell transplantation in an animal model of Huntingtons disease: behavioral and morphological outcomes. Int J Neurosci. 2003;113:945-56. (Pubitemid 36975650)
29. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: fi nal 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775-83. (Pubitemid 44871463)
30. Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, Willing AE, Gemma C, Bickford PC, et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One. 2008;3:e2494.
31. Mitrecic D, Nicaise C, Gajovic S, Pochet R. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transplant. 2010;19:537-48.
32. Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC, et al. Dose-dependent effi cacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett. 2010;468:190-4.
33. Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8: 94-109.
34. Boucherie C, Schafer S, Lavandh omme P, Maloteaux JM, Hermans E. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res. 2009;87:2034-46.
35. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076-84. (Pubitemid 44128350)
36. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 2006;198: 54-64. (Pubitemid 43243744)
37. Hedlund E, Hefferan MP, Marsala M, Isacson O. Cell therapy and stem cells in animal models of motor neuron disorders. Eur J Neurosci. 2007;26:1721-37. (Pubitemid 47493182)
38. Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, et al. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One. 2007;2:e1205.
39. Dewil M, dela Cruz VF, Van Den Bosch L, Robberecht W. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol Dis. 2007;26:332-41. (Pubitemid 46561336)
40. Rouaux C, Panteleeva I, Rene F, Gonzalez de Aguilar JL, Echaniz-Laguna A, Dupuis L, et al. Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci. 2007;27:5535-45. (Pubitemid 350021087)
41. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232-40. (Pubitemid 38084849)
42. Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm. 2007;114:1395-406. (Pubitemid 350112275)